Two brain inhibitors inhibit renal Na,K-ATPases without recognizing the species-dependent variation of their ouabain-sensitivity

Clinical and Experimental Hypertension

Volumn 20, Issue 5-6, 1998, Pages 489-497

  Anner, B M ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Hypertension; Hypothalamic inhibitor; Hypothalamic hypophysary inhibitor; K ATPase inhibition; Na; Ouabain pharmacology; Species dependence

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; HYPOTHALAMUS HYPOPHYSIS INHIBITOR; NATRIURETIC FACTOR; OUABAIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BASOLATERAL MEMBRANE; CHEMICAL STRUCTURE; CHROMATOGRAPHY; CONFERENCE PAPER; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HYPERTENSION; HYPOPHYSIS; HYPOTHALAMUS; KIDNEY; MASS SPECTROMETRY; MEMBRANE TRANSPORT; NONHUMAN; RABBIT; RAT; SHEEP; SODIUM ABSORPTION; SPECIES DIFFERENCE;

EID: 0031853988     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969809053227     Document Type: Conference Paper

References (31)

1. Jorgensen, P.L, Isolation of (Na + K)-ATPase. Methods Enzymol. 1974; 32: 277-290.
2. +-ATPase membrane transport system: importance in cellular function Curr Top Membrane Transp. 1972; 3: 2-80.
3. Schatzmann, H.-J Herzglykoside als Hemmstoffe für den aktiven Kalium- und Natriumtransport durch die Erythrocytenmembran Helv Physiol Acta. 1953; 11: 346-354.
4. Glynn, I.M. The action of cardiac glycosides on ion movements Pharmacol Rev. 1964; 16: 381-407
5. +)-activated ATPase. A biochemical link to digitalis-induced inotropy. Pharmacol Rev. 1984; 36: 143-163.
6. Goldin S.M., Tong, S.W. J Biol Chem. 1974; 249; 5907-5915.
7. Jorgensen, P.L. Mechanism of the Na,K-pump. Protein structure and conformations of the pure (Na + K)-ATPase. Biochim Biophys Acta. 1982; 694: 27-69.
8. Gonick, H.C., Kramer, H.J., Paul, W., Lu, E. Circulating inhibitor of sodium-potassium-activated adenosine-trisphosphatase after expansion of extracellular fluid volume in rats. Clin Sci Mol Med 1977; 53: 329-334.
9. Flier, J. S. Ouabain-like activity in toad skin and its implication for endogenous regulation of ion transport. Nature. 1978; 274: 285-286.
10. Buckalew, V.M., Gruber, K.A Natriuretic hormone. Ann Rev Physiol. 1984; 46: 343-358.
11. Blaustein, M.P., Hamlyn, J.M. Sodium transport inhibition, cell calcium and hypertension. The natriuretic hormone/ Na-Ca exchange/ hypertension hypothesis. Am J Med. 1984; Oct. 5: 45-59.
12. De Wardener, H.E., Clarkson, E.M. Concepts of natriuretic hormones. Physiol Rev. 1985; 65: 658-759.
13. Haber, E., Haupert, G.T. The search for a hypothalamic Na,K-ATPase inhibitor. Hypertension 1987; 9: 315-324.
14. Haddy, F.J Natriuretic hormone. N Engl J Med. 1987; 316: 621-623.
15. Goto, A., Yamada, K., Yagi, N, Yoshioka, M., Sugimoto, T. Physiology and pharmacology of endogenous digitalis-like factors Pharmacol Rev. 1992; 44: 377-395.
16. Hamlyn, J.M., Blaustein, M.P., Bova, S., DuCharme, D.W., Harris, D.W., Mandel, F., Mathews, W.R., Ludens, J.H. Identification and characterization of a ouabain-like compound from human plasma Proc Natl Acad Sci USA. 1991; 88: 6259-6263.
17. Tymiak, A:A:, Norman, J.A., Bolgar, M., DiDonato, G.C., Lee, H., Parker, W.L., Lo, L.-C., Berova N, Nakanishi K, Haber E, Haupert G.T. Jr. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci. 1993; 90 : 8189-8193.
18. Ferrandi, M., Minotti, E., Salardi, S. Florio, M. Bianchi G., Ferrari, P. The ouabain-like factor in the Milan hypertensive rats. Am J Physiol. 1992; 263: F739-F784.
19. Wechter, W.J., Benaksas, E. Natriuretic hormones. Progr Drug Res. 1990; 34: 231-260.
20. Blaustein, M.P. Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness Am J Physiol. 1993; 264: C1367-C1387.
21. Lichtstein, D., Samuelov, S., Gati, I., Wechter W.J. Digitalis-like compounds in animal tissue. J Bas Clin Physiol Pharmacol. 1992; 3: 269-292.
22. Anner, B.M., Rey, H.G., Moosmayer, M., Meszoely, I., Haupert, G.T., Jr. Hypothalamic Na,K-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na,K-ATPase. Am J Physiol 1990; 258: F144-F153.
23. +-pump inhibitors isolated from hypothalamus and hypophysis. FEBS 1990; 261:436-440.
24. Rodriguez-Barbero, A., Martinez-Salgado, C., Rodriguez-Lopez, A., Ricote, M., Sancho, J., Lopez-Novoa, J.M. Effect of hyopthalamic-hypophysary inhibitory factor on mesangial cell activation. Hypertension 1995; 26: 905-911.
25. Zhao, N., Lo, L-Ch., Berova, N., Nakanishi, K., Tymiak, A., Ludens, J., Haupert, G.T., Jr. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochem. 1995; 34: 9893-9896.
26. Dzhandzhugazyan, K.N., Jørgensen, P.L. Asymmetric orientation of amino groups in the -subunit and the -subunit of (Na+ + K+)- ATPase in tight right-side-out vesicles of basolateral membranes from outer medulla Biochim Biophys Acta. 1985; 817: 165-173.
27. Anner, B.M., M. Moosmayer, Imesch, E Mercury blocks Na,K-ATPase by a ligand-dependent and reversible mechanism. Am J Physiol. 1992, 262: F830-F836.$
28. Sweadner, K.J. Isozymes of Na+/K+-ATPase. Biochim Biophys Acta. 1989; 988: 185-220.
29. Repke, K., Est, M.,. Portius, H.J Ueber die Ursache der Speziesunterschiede in der Digitalisempfindlichkeit. Biochem Pharmacol. 1965; 14: 1785-1802.
30. Detweiler, D.K. Comparative pharmacology of cardiac glycosides Fed Proc. 1967 ;26 : 1119-1126.
31. Jewell, E.A., Lingrel, J.B. Comparison of the substrate dependence properties of the rat Na,K-ATPase 1, 2, and 3 isoforms expressed in HeLa cells. J Biol Chem 1991; 266: 16925-16930.